GERN vs TAP · rev $109.3M vs rev $13.04B
Geron Corporation (GERN) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Geron Corporation (GERN) is a biotechnology company listed on US.
TAP (TAP) common stock.
Latest reported GERN revenue for 2026-06-30 was $109.3M. Net income was -$20.3M. GERN currently screens at market cap $878.9M.
Latest reported TAP revenue for 2025-12-31 was $13.04B. Net income was -$2.14B. Revenue was down 5.1% from 2024-12-31 to 2025-12-31. TAP currently screens at market cap $0.
GERN currently screens at market cap $878.9M. TAP currently screens at market cap $0.
Not investment advice. Open the GERN and TAP stock pages for the full models.
Not investment advice.